HLA genotyping in the international Type 1 Diabetes Genetics Consortium

Clinical Trials

Volumn 7, Issue 1_suppl, 2010, Pages S75-S87

  Mychaleckyj, Josyf C ^a   Noble, Janelle A ^b   Moonsamy, Priscilla V ^c   Carlson, Joyce A ^d   Varney, Michael D ^e   Post, Jeff ^c   Helmberg, Wolfgang ^f   Pierce, June J ^g   Bonella, Persia ^c   Fear, Anna Lisa ^b   Lavant, Eva ^d   Louey, Anthony ^e   Boyle, Sean ^c   Lane, Julie A ^b   Sali, Paul ^c   Kim, Samuel ^c   Rappner, Rebecca ^d   Williams, Dustin T ^g   Perdue, Letitia H ^g   Reboussin, David M ^g   Tait, Brian D ^e   Akolkar, Beena ^h   Hilner, Joan E ⁱ   Steffes, Michael W ^j   Erlich, Henry A ^a,c   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e Australian Red Cross   (Australia)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; REAGENT;

ARTICLE; CERTIFICATION; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE LOCUS; GENETIC DATABASE; GENOTYPE; HLA TYPING; HUMAN; IMMUNOGENETICS; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY DEVICE; LABORATORY TEST; NOMENCLATURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SOFTWARE; STANDARDIZATION; SYSTEMATIC ERROR; ALGORITHM; BIOASSAY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EDUCATION; GENETIC POLYMORPHISM; GENETICS; HEALTH; INTERNATIONAL COOPERATION; PEDIGREE; RISK ASSESSMENT;

ALGORITHMS; BIOLOGICAL ASSAY; DIABETES MELLITUS, TYPE 1; EDUCATION; GENOTYPE; HLA ANTIGENS; HUMANS; INTERNATIONAL COOPERATION; LABORATORY TECHNIQUES AND PROCEDURES; PEDIGREE; POLYMORPHISM, GENETIC; QUALITY CONTROL; RISK ASSESSMENT; WORLD HEALTH;

EID: 79952279806     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774510373494     Document Type: Article

References (17)

1. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40: 1-14
2. Concannon P, Erlich HA, Julier C, et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005; 54: 2995-3001
3. Cox NJ, Wapelhorst B, Morrison VA, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001; 69: 820-30
4. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulindependent diabetes mellitus. Nature 1987; 329: 599-604
5. Cucca F, Muntoni F, Lampis R, et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94
6. Noble JA, Valdes AM, Cook M, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-48
7. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000; 49: 121-25
8. Nejentsev S, Howson JM,Walker NM, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887-92
9. Hilner JE, Perdue LH, Sides EG, et al. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clin Trials 2010; 7: S5-S32
10. Rosinger S, Nutland S, Mickelson E, et al. Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium. Clin Trials 2010; 7: S65-S74
11. Hall MA, King NMP, Perdue LH, et al. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials 2010; 7: S33-S45
12. Bugawan TL, Klitz W, Blair A, Erlich HA. Highresolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. Tissue Antigens 2000; 56: 392-404
13. Helmberg W, Zahn R, Keller E, et al. Virtual DNA analysis as a platform for interlaboratory data exchange of HLA DNA typing results. Tissue Antigens 1999; 54: 379-85
14. O?Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-66
15. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101
16. Robinson J, Malik A, Parham P, et al. IMGT/HLA database-a sequence database for the human major histocompatibility complex. Tissue Antigens 2000; 55: 280-87
17. Helmberg W, Hegland J, Hurley CK, et al. Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. Tissue Antigens 2000; 56: 99-102